Arrhythmic Risk Prediction in ARVC | 177 REFERENCES 1. Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med. 2017 Jan 5;376(1):61-72. 2. Groeneweg JA, Bhonsale A, James CA, et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015;8(3):437–46. 3. Calkins H, Corrado D, Marcus F. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2017;136(21):2068–82. 4. Cadrin-Tourigny J, Bosman LP, Nozza A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2019;40(23):1850-1858. 5. Baudinaud P, Laredo M, Badenco N, et al. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy. Canadian Journal of Cardiology. 2021;37(8):1263–6. 6. Aquaro GD, de Luca A, Cappelletto C, et al. Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy. ESC Heart Fail. 2020;7(6):4080–8. 7. Jordà P, Bosman LP, Gasperetti A, et al. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator. Eur Heart J. 2022;43(32):3041–52. 8. Protonotarios A, Bariani R, Cappelletto C, et al. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator. Eur Heart J. 2022;43(32):3053–67. 9. Carrick RT, te Riele ASJM, Gasperetti A, et al. Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol. 2022;15(11):e011207. 10. Kirkels FP, Lie ØH, Cramer MJ, et al. Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy. J Am Coll Cardiol Img. 2021;14(5):900-10. 11. Lie ØH, Rootwelt-Norberg C, Dejgaard LA, et al. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study. J Am Coll Cardiol Img. 2018;11(10):1377–86. 12. Sarvari SI, Haugaa KH, Anfinsen OG, et al. Right ventricular mechanical dispersion is related to malignant arrhythmias: A study of patients with arrhythmogenic right ventricular cardiomyopathy and subclinical right ventricular dysfunction. Eur Heart J. 2011;32(9):1089–96. 13. Leren IS, Saberniak J, Haland TF, Edvardsen T, Haugaa KH. Combination of ECG and Echocardiography for Identification of Arrhythmic Events in Early ARVC. J Am Coll Cardiol Img. 2017 May;10(5):503–13. 14. Rootwelt-Norberg C, Lie ØH, Chivulescu M, et al. Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy. Europace. 2021;23(7):1084-91. 15. Mast TP, Teske AJ, Walmsley J, et al. Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2016 Nov;68(20):2185–97. 8
RkJQdWJsaXNoZXIy MTk4NDMw